biological indicators market REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The global biological indicators market size was in USD 337.76 million 2021 and is expected to reach USD 589.99 million by 2027, exhibiting a CAGR of 9.74% during the forecast period. The COVID-19 pandemic has been unprecedented and staggering, with experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden decline in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.
The biological indicators, commonly known as BIs or biological indicator strips, serve as indispensable instruments employed across diverse industries to evaluate the efficiency of sterilization procedures. Their significance is most pronounced in healthcare environments, pharmaceutical production, and the food sector, where the imperative is to ensure the complete eradication of detrimental microorganisms.
COVID-19 Impact: Increased Demand for Sterilization among Population to Fuel Market Growth
The increased focus on infection control during the pandemic has generated a greater need for the sterilization of medical equipment, PPE, and healthcare facilities. This upsurge in sterilization demands has, in turn, bolstered the necessity for biological indicators, given their essential role in confirming the efficiency of sterilization procedures.
Similar to numerous other goods, biological indicators have encountered supply chain interruptions stemming from lockdowns, transport constraints, and production delays. These disturbances have resulted in scarcities and setbacks in the accessibility of biological indicators.
LATEST TRENDS
"Increased Use in Healthcare, and Pharmaceutical Industry Growth to Fuel Market Growth "
The COVID-19 pandemic has emphasized the utmost importance of infection control within healthcare settings. To curtail the virus's spread, healthcare institutions had to uphold the highest standards of sterilization and cleanliness. Biological indicators stand as indispensable tools for validating the efficacy of sterilization processes, encompassing the sterilization of medical equipment, surgical instruments, and even the healthcare facilities themselves. In healthcare, patient safety is the paramount concern, and any lapse in sterilization procedures can result in life-threatening healthcare-associated infections (HAIs). The deployment of biological indicators ensures that healthcare establishments rigorously adhere to infection control measures, thereby diminishing the risk of HAIs and enhancing overall patient safety. Moreover, healthcare facilities are obliged to adhere to stringent regulatory standards and guidelines, which encompass demanding sterilization and disinfection protocols. The pharmaceutical industry has been witnessing growth, and the indispensable role of biological indicators in guaranteeing the sterility and safety of pharmaceutical production is anticipated to persist, fueled by ongoing research and development activities within the pharmaceutical sector.
biological indicators market SEGMENTATION
-
Request a Free Sample to learn more about this report
- By Type
Based on type market is classified as self-contained biological indicator and biological indicator strip.
- By Application
Based on application the market is classified as hospital, pharma companies and other.
DRIVING FACTORS
"Rising Awareness of Infection Control to Fuel Market Growth"
The heightened awareness of infection control's significance, especially within healthcare settings, has strongly driven biological indicators market growth. This growth is underpinned by the essential role that biological indicators play in validating the effectiveness of sterilization processes, a critical component of infection prevention.
"Expanding Healthcare Sector to Stimulate Market Progress"
The expansion of the healthcare sector, propelled by factors like an aging population and advancements in medical technology, has resulted in a heightened need for biological indicators. These indicators are indispensable for healthcare institutions, medical device manufacturers, and pharmaceutical companies in their efforts to uphold sterility and ensure patient safety.
RESTRAINING FACTOR
"High Cost of Biological Indicators to Harm Market Growth "
The adoption of biological indicators, especially the more advanced and technologically sophisticated variants, can be impeded by their relatively high cost. This cost factor may pose a hurdle for smaller healthcare facilities, laboratories, or businesses, restricting their ability to integrate these indicators into their processes.
biological indicators market REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"North America to dominate the Market owing to Growing Emphasis On Sustainable And Eco-Friendly Solutions "
North America, encompassing the U.S. and Canada, commands a significant biological indicators market share due to its well-established healthcare system and rigorous regulatory standards. This region stands as a dominant consumer of biological indicators, primarily within healthcare and pharmaceutical manufacturing. The market share in North America is further bolstered by the presence of top-tier pharmaceutical and biotechnology companies. These entities drive demand for biological indicators, a crucial component for upholding product quality and ensuring patient safety. Recent years have witnessed a growing emphasis on sustainable and eco-friendly solutions, which has led to the development of more environmentally responsible biological indicators, further solidifying North America's prominent position in the market.
KEY INDUSTRY PLAYERS
"Multitude of Companies That Played A Pivotal Role In Expansion Of Biological Indicators "
Within the market, you'll find a range of influential industry leaders, encompassing manufacturers, distributors, and service providers specializing in biological indicators and sterilization monitoring solutions. One notable example is 3M, a multifaceted technology company renowned for its healthcare offerings, which include biological indicators essential for monitoring sterilization processes.
List of Market Players Profiled
- Baumer S.A (Switzerland)
- Fuze Medicine Equipment (New Jersey)
- Cantel Medical (U.S.)
- Etigam (Netherlands)
- 3M (U.S.)
REPORT COVERAGE
The future demand for the market is covered in this study. The Research report includes the Increased Demand for Sterilization due to the Covid-19 Impact. The report covers the latest trends in Increased Use in Healthcare. The paper includes a segmentation of the biological indicators market. The research paper includes the driving factors that are Rising Awareness of Infection Control to Fuel Market Growth. The report also covers information on Regional Insights where the region which has emerged leading market for biological indicators.
| REPORT COVERAGE | DETAILS |
|---|---|
Market Size Value In |
US$ 337.76 Million in 2021 |
Market Size Value By |
US$ 589.99 Million by 2027 |
Growth Rate |
CAGR of 9.74% from 2021 to 2027 |
Forecast Period |
2022-2027 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the biological indicators market expected to touch by 2027?
The global biological indicators market size is expected to reach USD 589.99 million by 2027.
-
What CAGR is the global biological indicators market expected to exhibit by 2027?
The global biological indicators market is expected to exhibit a CAGR of 9.74% by 2027.
-
Which are the driving factors of the biological indicators market?
The driving factors of the biological indicators market are Rising Awareness of Infection Control, and Expanding Healthcare Sector.
-
Which are the key players or most dominating companies functioning in the biological indicators market?
Baumer S.A, Fuze Medicine Equipment, Cantel Medical, Etigam, and 3M are the key players or most dominating companies functioning in the biological indicators market.
